Nicotinic Cholinergic Mechanisms in Alzheimer's Disease

International Review of Neurobiology

Volumn 124, Issue , 2015, Pages 275-292

  Shen, Jianxin ^a   Wu, Jie ^a,b  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Alzheimer's disease; Amyloid peptides; Learning and memory deficits; Nicotinic acetylcholine receptors; Toxicity

Indexed keywords

AMYLOID BETA PROTEIN; BUNGAROTOXIN RECEPTOR; CHOLINERGIC RECEPTOR STIMULATING AGENT;

ALZHEIMER DISEASE; BRAIN NERVE CELL; CHOLINERGIC SYSTEM; COGNITION; HUMAN; LEARNING; MEMORY; NEUROPROTECTION; NEUROTOXICITY; NEUROTRANSMITTER RELEASE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; ANIMAL; COMPLICATION; METABOLISM;

ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; CHOLINERGIC AGENTS; HUMANS;

EID: 84945405611     PISSN: 00747742     EISSN: 21625514     Source Type: Book Series    
DOI: 10.1016/bs.irn.2015.08.002     Document Type: Chapter

References (120)

1. Albuquerque E.X., Alkondon M., Pereira E.F., Castro N.G., Schrattenholz A., Barbosa C.T., et al. Properties of neuronal nicotinic acetylcholine receptors: Pharmacological characterization and modulation of synaptic function. The Journal of Pharmacology and Experimental Therapeutics 1997, 280(3):1117-1136.
2. Albuquerque E.X., Pereira E.F., Castro N.G., Alkondon M., Reinhardt S., Schroder H., et al. Nicotinic receptor function in the mammalian central nervous system. Annals of the New York Academy of Sciences 1995, 757:48-72.
3. Alkondon M., Albuquerque E.X. Initial characterization of the nicotinic acetylcholine receptors in rat hippocampal neurons. Journal of Receptor Research 1991, 11(6):1001-1021.
4. Alkondon M., Albuquerque E.X. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. I. Pharmacological and functional evidence for distinct structural subtypes. The Journal of Pharmacology and Experimental Therapeutics 1993, 265(3):1455-1473.
5. Amatniek J.C., Hauser W.A., DelCastillo-Castaneda C., Jacobs D.M., Marder K., Bell K., et al. Incidence and predictors of seizures in patients with Alzheimer's disease. Epilepsia 2006, 47(5):867-872.
6. Arispe N., Pollard H.B., Rojas E. beta-Amyloid Ca(2+)-channel hypothesis for neuronal death in Alzheimer disease. Molecular and Cellular Biochemistry 1994, 140(2):119-125.
7. Avdulov N.A., Chochina S.V., Igbavboa U., O'Hare E.O., Schroeder F., Cleary J.P., et al. Amyloid beta-peptides increase annular and bulk fluidity and induce lipid peroxidation in brain synaptic plasma membranes. Journal of Neurochemistry 1997, 68(5):2086-2091.
8. Azam L., Winzer-Serhan U., Leslie F.M. Co-expression of alpha7 and beta2 nicotinic acetylcholine receptor subunit mRNAs within rat brain cholinergic neurons. Neuroscience 2003, 119(4):965-977.
9. Broide R.S., Salas R., Ji D., Paylor R., Patrick J.W., Dani J.A., et al. Increased sensitivity to nicotine-induced seizures in mice expressing the L250T alpha 7 nicotinic acetylcholine receptor mutation. Molecular Pharmacology 2002, 61(3):695-705.
10. Burghaus L., Schutz U., Krempel U., de Vos R.A., Jansen Steur E.N., Wevers A., et al. Quantitative assessment of nicotinic acetylcholine receptor proteins in the cerebral cortex of Alzheimer patients. Brain Research. Molecular Brain Research 2000, 76(2):385-388.
11. Busche M.A., Eichhoff G., Adelsberger H., Abramowski D., Wiederhold K.H., Haass C., et al. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease. Science 2008, 321(5896):1686-1689.
12. Champtiaux N., Gotti C., Cordero-Erausquin M., David D.J., Przybylski C., Lena C., et al. Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice. The Journal of Neuroscience 2003, 23(21):7820-7829.
13. Chin J.H., Ma L., MacTavish D., Jhamandas J.H. Amyloid beta protein modulates glutamate-mediated neurotransmission in the rat basal forebrain: Involvement of presynaptic neuronal nicotinic acetylcholine and metabotropic glutamate receptors. The Journal of Neuroscience 2007, 27(35):9262-9269. 10.1523/JNEUROSCI.1843-07.2007.
14. Clarke P.B. The fall and rise of neuronal alpha-bungarotoxin binding proteins. Trends in Pharmacological Sciences 1992, 13(11):407-413.
15. Cleary J.P., Walsh D.M., Hofmeister J.J., Shankar G.M., Kuskowski M.A., Selkoe D.J., et al. Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nature Neuroscience 2005, 8(1):79-84.
16. Cooper S.T., Harkness P.C., Baker E.R., Millar N.S. Up-regulation of cell-surface alpha4beta2 neuronal nicotinic receptors by lower temperature and expression of chimeric subunits. The Journal of Biological Chemistry 1999, 274(38):27145-27152.
17. Counts S.E., He B., Che S., Ikonomovic M.D., DeKosky S.T., Ginsberg S.D., et al. Alpha7 nicotinic receptor up-regulation in cholinergic basal forebrain neurons in Alzheimer disease. Archives of Neurology 2007, 64(12):1771-1776. 10.1001/archneur.64.12.1771.
18. Couturier S., Bertrand D., Matter J.M., Hernandez M.C., Bertrand S., Millar N., et al. A neuronal nicotinic acetylcholine receptor subunit (alpha 7) is developmentally regulated and forms a homo-oligomeric channel blocked by alpha-BTX. Neuron 1990, 5(6):847-856.
19. Dajas-Bailador F.A., Wonnacott S. Nicotinic acetylcholine receptors and the regulation of neuronal signalling. Trends in Pharmacological Sciences 2004, 25(6):317-324.
20. Damaj M.I., Glassco W., Dukat M., Martin B.R. Pharmacological characterization of nicotine-induced seizures in mice. The Journal of Pharmacology and Experimental Therapeutics 1999, 291(3):1284-1291.
21. Del Vecchio R.A., Gold L.H., Novick S.J., Wong G., Hyde L.A. Increased seizure threshold and severity in young transgenic CRND8 mice. Neuroscience Letters 2004, 367(2):164-167.
22. Dineley K.T. Beta-amyloid peptide-nicotinic acetylcholine receptor interaction: The two faces of health and disease. Frontiers in Bioscience 2007, 12:5030-5038.
23. Dineley K.T., Bell K.A., Bui D., Sweatt J.D. Beta-amyloid peptide activates alpha 7 nicotinic acetylcholine receptors expressed in Xenopus oocytes. The Journal of Biological Chemistry 2002, 277(28):25056-25061.
24. Dineley K.T., Pandya A.A., Yakel J.L. Nicotinic ACh receptors as therapeutic targets in CNS disorders. Trends in Pharmacological Sciences 2015, 36(2):96-108.
25. Dineley K.T., Westerman M., Bui D., Bell K., Ashe K.H., Sweatt J.D. Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease. The Journal of Neuroscience 2001, 21(12):4125-4133.
26. Dineley K.T., Xia X., Bui D., Sweatt J.D., Zheng H. Accelerated plaque accumulation, associative learning deficits, and up-regulation of alpha 7 nicotinic receptor protein in transgenic mice co-expressing mutant human presenilin 1 and amyloid precursor proteins. The Journal of Biological Chemistry 2002, 277(25):22768-22780.
27. Dolezal V., Kasparova J. Beta-amyloid and cholinergic neurons. Neurochemical Research 2003, 28(3-4):499-506.
28. Dougherty J.J., Wu J., Nichols R.A. Beta-amyloid regulation of presynaptic nicotinic receptors in rat hippocampus and neocortex. The Journal of Neuroscience 2003, 23(17):6740-6747.
29. Durazzo T.C., Mattsson N., Weiner M.W., Alzheimer's Disease Neuroimaging I. Smoking and increased Alzheimer's disease risk: A review of potential mechanisms. Alzheimers Dement 2014, 10(3 Suppl.):S122-S145.
30. Dziewczapolski G., Glogowski C.M., Masliah E., Heinemann S.F. Deletion of the alpha 7 nicotinic acetylcholine receptor gene improves cognitive deficits and synaptic pathology in a mouse model of Alzheimer's disease. The Journal of Neuroscience 2009, 29(27):8805-8815.
31. Edwards-Lee T., Cook I., Fairbanks L., Leuchter A., Cummings J.L. Quantitative electroencephalographic correlates of psychosis in Alzheimer disease. Neuropsychiatry, Neuropsychology, and Behavioral Neurology 2000, 13(3):163-170.
32. Feuerbach D., Lingenhoehl K., Olpe H.R., Vassout A., Gentsch C., Chaperon F., et al. The selective nicotinic acetylcholine receptor alpha7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain. Neuropharmacology 2009, 56(1):254-263.
33. Franceschini D., Paylor R., Broide R., Salas R., Bassetto L., Gotti C., et al. Absence of alpha7-containing neuronal nicotinic acetylcholine receptors does not prevent nicotine-induced seizures. Brain Research. Molecular Brain Research 2002, 98(1-2):29-40.
34. Fraser S.P., Suh Y.H., Djamgoz M.B. Ionic effects of the Alzheimer's disease beta-amyloid precursor protein and its metabolic fragments. Trends in Neurosciences 1997, 20(2):67-72.
35. Fratiglioni L., Wang H.X. Smoking and Parkinson's and Alzheimer's disease: Review of the epidemiological studies. Behavioural Brain Research 2000, 113(1-2):117-120.
36. 2+ permeability of nicotinic acetylcholine receptors. Cell Calcium 2004, 35(1):1-8. Journal article review.
37. Geerts H. Indicators of neuroprotection with galantamine. Brain Research Bulletin 2005, 64(6):519-524.
38. Gil Z., Sack R.A., Kedmi M., Harmelin A., Orr-Urtreger A. Increased sensitivity to nicotine-induced seizures in mice heterozygous for the L250T mutation in the alpha7 nicotinic acetylcholine receptor. Neuroreport 2002, 13(2):191-196.
39. Gotti C., Carbonnelle E., Moretti M., Zwart R., Clementi F. Drugs selective for nicotinic receptor subtypes: A real possibility or a dream?. Behavioural Brain Research 2000, 113(1-2):183-192.
40. Grilli M., Raiteri L., Patti L., Parodi M., Robino F., Raiteri M., et al. Modulation of the function of presynaptic alpha7 and non-alpha7 nicotinic receptors by the tryptophan metabolites, 5-hydroxyindole and kynurenate in mouse brain. British Journal of Pharmacology 2006, 149(6):724-732.
41. Hellstrom-Lindahl E., Court J., Keverne J., Svedberg M., Lee M., Marutle A., et al. Nicotine reduces A beta in the brain and cerebral vessels of APPsw mice. The European Journal of Neuroscience 2004, 19(10):2703-2710.
42. Hellstrom-Lindahl E., Mousavi M., Ravid R., Nordberg A. Reduced levels of Abeta 40 and Abeta 42 in brains of smoking controls and Alzheimer's patients. Neurobiology of Disease 2004, 15(2):351-360.
43. Hellstrom-Lindahl E., Mousavi M., Zhang X., Ravid R., Nordberg A. Regional distribution of nicotinic receptor subunit mRNAs in human brain: Comparison between Alzheimer and normal brain. Brain Research. Molecular Brain Research 1999, 66(1-2):94-103.
44. Hernandez C.M., Dineley K.T. alpha7 nicotinic acetylcholine receptors in Alzheimer's disease: Neuroprotective, neurotrophic or both?. Current Drug Targets 2012, 13(5):613-622.
45. Hernandez C.M., Kayed R., Zheng H., Sweatt J.D., Dineley K.T. Loss of alpha7 nicotinic receptors enhances beta-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer's disease. The Journal of Neuroscience 2010, 30(7):2442-2453.
46. Hesdorffer D.C., Hauser W.A., Annegers J.F., Kokmen E., Rocca W.A. Dementia and adult-onset unprovoked seizures. Neurology 1996, 46(3):727-730.
47. Hommet C., Mondon K., Camus V., De Toffol B., Constans T. Epilepsy and dementia in the elderly. Dementia and Geriatric Cognitive Disorders 2008, 25(4):293-300.
48. Hsia A.Y., Masliah E., McConlogue L., Yu G.Q., Tatsuno G., Hu K., et al. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proceedings of the National Academy of Sciences of the United States of America 1999, 96(6):3228-3233.
49. Ikonomovic M.D., Wecker L., Abrahamson E.E., Wuu J., Counts S.E., Ginsberg S.D., et al. Cortical alpha7 nicotinic acetylcholine receptor and beta-amyloid levels in early Alzheimer disease. Archives of Neurology 2009, 66(5):646-651.
50. Jones I.W., Westmacott A., Chan E., Jones R.W., Dineley K., O'Neill M.J., et al. Alpha7 nicotinic acetylcholine receptor expression in Alzheimer's disease: Receptor densities in brain regions of the APP(SWE) mouse model and in human peripheral blood lymphocytes. Journal of Molecular Neuroscience 2006, 30(1-2):83-84.
51. Jones I.W., Wonnacott S. Precise localization of alpha7 nicotinic acetylcholine receptors on glutamatergic axon terminals in the rat ventral tegmental area. The Journal of Neuroscience 2004, 24(50):11244-11252.
52. Kanfer J.N., Sorrentino G., Sitar D.S. Amyloid beta peptide membrane perturbation is the basis for its biological effects. Neurochemical Research 1999, 24(12):1621-1630.
53. Khiroug S.S., Harkness P.C., Lamb P.W., Sudweeks S.N., Khiroug L., Millar N.S., et al. Rat nicotinic ACh receptor alpha7 and beta2 subunits co-assemble to form functional heteromeric nicotinic receptor channels. The Journal of Physiology 2002, 540(Pt. 2):425-434.
54. Lahiri D.K., Utsuki T., Chen D., Farlow M.R., Shoaib M., Ingram D.K., et al. Nicotine reduces the secretion of Alzheimer's beta-amyloid precursor protein containing beta-amyloid peptide in the rat without altering synaptic proteins. Annals of the New York Academy of Sciences 2002, 965:364-372.
55. Lamb P.W., Melton M.A., Yakel J.L. Inhibition of neuronal nicotinic acetylcholine receptor channels expressed in Xenopus oocytes by beta-amyloid1-42 peptide. Journal of Molecular Neuroscience 2005, 27(1):13-21.
56. Larner A.J. Epileptic seizures in AD patients. Neuromolecular Medicine 2010, 12(1):71-77.
57. Leonard A.S., McNamara J.O. Does epileptiform activity contribute to cognitive impairment in Alzheimer's disease?. Neuron 2007, 55(5):677-678.
58. Lesne S., Koh M.T., Kotilinek L., Kayed R., Glabe C.G., Yang A., et al. A specific amyloid-beta protein assembly in the brain impairs memory. Nature 2006, 440(7082):352-357. 10.1038/nature04533.
59. Levin E.D., Rezvani A.H. Nicotinic treatment for cognitive dysfunction. Current Drug Targets. CNS and Neurological Disorders 2002, 1(4):423-431.
60. Lin H., Vicini S., Hsu F.C., Doshi S., Takano H., Coulter D.A., et al. Axonal alpha7 nicotinic ACh receptors modulate presynaptic NMDA receptor expression and structural plasticity of glutamatergic presynaptic boutons. Proceedings of the National Academy of Sciences of the United States of America 2010, 107(38):16661-16666.
61. Lindstrom J. Neuronal nicotinic acetylcholine receptors. Ion Channels 1996, 4:377-450.
62. Liu Q., Huang Y., Xue F., Simard A., DeChon J., Li G., et al. A novel nicotinic acetylcholine receptor subtype in basal forebrain cholinergic neurons with high sensitivity to amyloid peptides. The Journal of Neuroscience 2009, 29(4):918-929.
63. Liu Q., Kawai H., Berg D.K. Beta-amyloid peptide blocks the response of alpha 7-containing nicotinic receptors on hippocampal neurons. Proceedings of the National Academy of Sciences of the United States of America 2001, 98(8):4734-4739.
64. Liu Q., Wu J. Neuronal nicotinic acetylcholine receptors serve as sensitive targets that mediate beta-amyloid neurotoxicity. Acta Pharmacologica Sinica 2006, 27(10):1277-1286.
65. Liu Q., Xie X., Emadi S., Sierks M.R., Wu J. A novel nicotinic mechanism underlies beta-amyloid-induced neurotoxicity. Neuropharmacology 2015, 97:457-463.
66. Liu Q., Xie X., Lukas R.J., St John P.A., Wu J. A novel nicotinic mechanism underlies beta-amyloid-induced neuronal hyperexcitation. The Journal of Neuroscience 2013, 33(17):7253-7263.
67. Liu Q., Zhang J., Zhu H., Qin C., Chen Q., Zhao B. Dissecting the signaling pathway of nicotine-mediated neuroprotection in a mouse Alzheimer disease model. The FASEB Journal 2007, 21(1):61-73.
68. Lombardo S., Maskos U. Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment. Neuropharmacology 2015, 96(Pt. B):255-262.
69. Lozsadi D.A., Larner A.J. Prevalence and causes of seizures at the time of diagnosis of probable Alzheimer's disease. Dementia and Geriatric Cognitive Disorders 2006, 22(2):121-124.
70. Lukas R.J., Changeux J.P., Le Novère N., Albuquerque E.X., Balfour D.J., Berg D.K., et al. International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. Pharmacological Reviews 1999, 51(2):397-401.
71. Machaalani R., Kashi P.K., Waters K.A. Distribution of nicotinic acetylcholine receptor subunits alpha7 and beta2 in the human brainstem and hippocampal formation. Journal of Chemical Neuroanatomy 2010, 40(3):223-231.
72. Marcon G., Giaccone G., Cupidi C., Balestrieri M., Beltrami C.A., Finato N., et al. Neuropathological and clinical phenotype of an Italian Alzheimer family with M239V mutation of presenilin 2 gene. Journal of Neuropathology and Experimental Neurology 2004, 63(3):199-209.
73. McGehee D.S., Role L.W. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annual Review of Physiology 1995, 57:521-546.
74. Mendez M.F. Huntington's disease: Update and review of neuropsychiatric aspects. International Journal of Psychiatry in Medicine 1994, 24(3):189-208.
75. Mendez M., Lim G. Seizures in elderly patients with dementia: Epidemiology and management. Drugs & Aging 2003, 20(11):791-803.
76. Miner L.L., Collins A.C. Strain comparison of nicotine-induced seizure sensitivity and nicotinic receptors. Pharmacology, Biochemistry, and Behavior 1989, 33(2):469-475.
77. Miner L.L., Marks M.J., Collins A.C. Classical genetic analysis of nicotine-induced seizures and nicotinic receptors. The Journal of Pharmacology and Experimental Therapeutics 1984, 231(3):545-554.
78. Miner L.L., Marks M.J., Collins A.C. Relationship between nicotine-induced seizures and hippocampal nicotinic receptors. Life Sciences 1985, 37(1):75-83.
79. Minkeviciene R., Rheims S., Dobszay M.B., Zilberter M., Hartikainen J., Fulop L., et al. Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy. The Journal of Neuroscience 2009, 29(11):3453-3462.
80. Molinari E.J., Delbono O., Messi M.L., Renganathan M., Arneric S.P., Sullivan J.P., et al. Up-regulation of human alpha7 nicotinic receptors by chronic treatment with activator and antagonist ligands. European Journal of Pharmacology 1998, 347(1):131-139.
81. Moretti M., Zoli M., George A.A., Lukas R.J., Pistillo F., Maskos U., et al. The novel alpha7beta2-nicotinic acetylcholine receptor subtype is expressed in mouse and human basal forebrain: Biochemical and pharmacological characterization. Molecular Pharmacology 2014, 86(3):306-317.
82. Muller W.E., Koch S., Eckert A., Hartmann H., Scheuer K. beta-Amyloid peptide decreases membrane fluidity. Brain Research 1995, 674(1):133-136. 0006-8993(94)01463-R [pii].
83. Murray T.A., Bertrand D., Papke R.L., George A.A., Pantoja R., Srinivasan R., et al. alpha7beta2 nicotinic acetylcholine receptors assemble, function, and are activated primarily via their alpha7-alpha7 interfaces. Molecular Pharmacology 2012, 81(2):175-188.
84. Murray T., Srinivasan R., Liu Q., Maxwell J., Pantoja R., Whiteaker P., et al. Coassembly of fluorescently-tagged α7 and β2 nicotinic acetylcholine receptor subunits in mammalian cell line detected by FRET 2009, Society for Neuroscience, Chicago, IL, Online, Program No. 227.12/C8.
85. Nagele R.G., D'Andrea M.R., Anderson W.J., Wang H.Y. Intracellular accumulation of beta-amyloid(1-42) in neurons is facilitated by the alpha 7 nicotinic acetylcholine receptor in Alzheimer's disease. Neuroscience 2002, 110(2):199-211.
86. Nashmi R., Dickinson M.E., McKinney S., Jareb M., Labarca C., Fraser S.E., et al. Assembly of alpha4beta2 nicotinic acetylcholine receptors assessed with functional fluorescently labeled subunits: Effects of localization, trafficking, and nicotine-induced upregulation in clonal mammalian cells and in cultured midbrain neurons. The Journal of Neuroscience 2003, 23(37):11554-11567.
87. Nordberg A. Nicotinic receptor abnormalities of Alzheimer's disease: Therapeutic implications. Biological Psychiatry 2001, 49(3):200-210. S0006322300011252 [pii].
88. Onaivi E.S., Ishiguro H., Gu S., Liu Q.R. CNS effects of CB2 cannabinoid receptors: Beyond neuro-immuno-cannabinoid activity. Journal of Psychopharmacology 2012, 26(1):92-103.
89. Orr-Urtreger A., Goldner F.M., Saeki M., Lorenzo I., Goldberg L., De Biasi M., et al. Mice deficient in the alpha7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotinic currents. The Journal of Neuroscience 1997, 17(23):9165-9171.
90. Palop J.J., Chin J., Roberson E.D., Wang J., Thwin M.T., Bien-Ly N., et al. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron 2007, 55(5):697-711.
91. Palop J.J., Mucke L. Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: From synapses toward neural networks. Nature Neuroscience 2010, 13(7):812-818.
92. Parri H.R., Hernandez C.M., Dineley K.T. Research update: Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease. Biochemical Pharmacology 2011, 82(8):931-942.
93. Pettit D.L., Shao Z., Yakel J.L. beta-Amyloid(1-42) peptide directly modulates nicotinic receptors in the rat hippocampal slice. The Journal of Neuroscience 2001, 21(1):Rc120.
94. Puchacz E., Buisson B., Bertrand D., Lukas R.J. Functional expression of nicotinic acetylcholine receptors containing rat alpha 7 subunits in human SH-SY5Y neuroblastoma cells. FEBS Letters 1994, 354(2):155-159.
95. Rabinowicz A.L., Starkstein S.E., Leiguarda R.C., Coleman A.E. Transient epileptic amnesia in dementia: A treatable unrecognized cause of episodic amnestic wandering. Alzheimer Disease and Associated Disorders 2000, 14(4):231-233.
96. Sadot E., Gurwitz D., Barg J., Behar L., Ginzburg I., Fisher A. Activation of m1 muscarinic acetylcholine receptor regulates tau phosphorylation in transfected PC12 cells. Journal of Neurochemistry 1996, 66(2):877-880.
97. Sanderson K.L., Butler L., Ingram V.M. Aggregates of a beta-amyloid peptide are required to induce calcium currents in neuron-like human teratocarcinoma cells: Relation to Alzheimer's disease. Brain Research 1997, 744(1):7-14.
98. Sargent P.B., Bryan G.K., Streichert L.C., Garrett E.N. Denervation does not alter the number of neuronal bungarotoxin binding sites on autonomic neurons in the frog cardiac ganglion. The Journal of Neuroscience 1991, 11(11):3610-3623.
99. Sargent P.B., Garrett E.N. The characterization of alpha-bungarotoxin receptors on the surface of parasympathetic neurons in the frog heart. Brain Research 1995, 680(1-2):99-107.
100. Schmidt J.T., Freeman J.A. Electrophysiologic evidence that retinotectal synaptic transmission in the goldfish is nicotinic cholinergic. Brain Research 1980, 187(1):129-142.
101. Scholze P., Ciuraszkiewicz A., Groessl F., Orr-Urtreger A., McIntosh J.M., Huck S. alpha4beta2 nicotinic acetylcholine receptors in the early postnatal mouse superior cervical ganglion. Developmental Neurobiology 2011, 71(5):390-399.
102. Seguela P., Wadiche J., Dineley-Miller K., Dani J.A., Patrick J.W. Molecular cloning, functional properties, and distribution of rat brain alpha 7: A nicotinic cation channel highly permeable to calcium. The Journal of Neuroscience 1993, 13(2):596-604.
103. Selkoe D.J. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 1999, 399(6738 Suppl.):A23-A31.
104. Shen J.X., Yakel J.L. Nicotinic acetylcholine receptor-mediated calcium signaling in the nervous system. Acta Pharmacologica Sinica 2009, 30(6):673-680.
105. Skok V.I. Nicotinic acetylcholine receptors in autonomic ganglia. Autonomic Neuroscience 2002, 97(1):1-11.
106. Snider B.J., Norton J., Coats M.A., Chakraverty S., Hou C.E., Jervis R., et al. Novel presenilin 1 mutation (S170F) causing Alzheimer disease with Lewy bodies in the third decade of life. Archives of Neurology 2005, 62(12):1821-1830.
107. Spencer J.P., Weil A., Hill K., Hussain I., Richardson J.C., Cusdin F.S., et al. Transgenic mice over-expressing human beta-amyloid have functional nicotinic alpha 7 receptors. Neuroscience 2006, 137(3):795-805. 10.1016/j.neuroscience.2005.10.007.
108. Szabo S.I., Zelles T., Lendvai B. Intracellular Ca2+ dynamics of hippocampal interneurons following nicotinic acetylcholine receptor activation. Neurochemistry International 2008, 52(1-2):135-141.
109. Thomsen M.S., Zwart R., Ursu D., Jensen M.M., Pinborg L.H., Gilmour G., et al. alpha7 and beta2 nicotinic acetylcholine receptor subunits form heteromeric receptor complexes that are expressed in the human cortex and display distinct pharmacological properties. PLoS One 2015, 10(6):e0130572.
110. Uteshev V.V. Evaluation of Ca2+ permeability of nicotinic acetylcholine receptors in hypothalamic histaminergic neurons. Acta Pharmacologica Sinica 2010, 42(1):8-20.
111. Valles A.S., Borroni M.V., Barrantes F.J. Targeting brain alpha7 nicotinic acetylcholine receptors in Alzheimer's disease: Rationale and current status. CNS Drugs 2014, 28(11):975-987.
112. 2+. Neuron 1992, 8(2):353-362. Journal article.
113. Wang H.Y., Lee D.H., D'Andrea M.R., Peterson P.A., Shank R.P., Reitz A.B. beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology. The Journal of Biological Chemistry 2000, 275(8):5626-5632.
114. Wang H.Y., Lee D.H., Davis C.B., Shank R.P. Amyloid peptide Abeta(1-42) binds selectively and with picomolar affinity to alpha7 nicotinic acetylcholine receptors. Journal of Neurochemistry 2000, 75(3):1155-1161.
115. Westmark C.J., Westmark P.R., Beard A.M., Hildebrandt S.M., Malter J.S. Seizure susceptibility and mortality in mice that over-express amyloid precursor protein. International Journal of Clinical and Experimental Pathology 2008, 1(2):157-168.
116. Wu J., George A.A., Schroeder K.M., Xu L., Marxer-Miller S., Lucero L., et al. Electrophysiological, pharmacological, and molecular evidence for alpha7-nicotinic acetylcholine receptors in rat midbrain dopamine neurons. The Journal of Pharmacology and Experimental Therapeutics 2004, 311(1):80-91.
117. Wu J., Kuo Y.P., George A.A., Xu L., Hu J., Lukas R.J. beta-Amyloid directly inhibits human alpha4beta2-nicotinic acetylcholine receptors heterologously expressed in human SH-EP1 cells. The Journal of Biological Chemistry 2004, 279(36):37842-37851.
118. Xiu J., Nordberg A., Zhang J.T., Guan Z.Z. Expression of nicotinic receptors on primary cultures of rat astrocytes and up-regulation of the alpha7, alpha4 and beta2 subunits in response to nanomolar concentrations of the beta-amyloid peptide(1-42). Neurochemistry International 2005, 47(4):281-290.
119. Yu W.F., Guan Z.Z., Bogdanovic N., Nordberg A. High selective expression of alpha7 nicotinic receptors on astrocytes in the brains of patients with sporadic Alzheimer's disease and patients carrying Swedish APP 670/671 mutation: A possible association with neuritic plaques. Experimental Neurology 2005, 192(1):215-225.
120. Zorumski C.F., Thio L.L., Isenberg K.E., Clifford D.B. Nicotinic acetylcholine currents in cultured postnatal rat hippocampal neurons. Molecular Pharmacology 1992, 41(5):931-936.